Levofloxacino Tarbis

Levofloxacin, the active ingredient in Levofloxacino Tarbis, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional. It is indicated for infections of the respiratory, urinary and skin systems and is effective against both Gram‑positive and Gram‑negative pathogens.

GNH USA supplies Levofloxacino Tarbis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑ready documentation for each batch.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections affecting several organ systems.

- Community‑Acquired Pneumonia: shortens disease duration and improves clinical cure rates in adults. - Acute Bacterial Sinusitis: eradicates the causative pathogens, relieving sinus congestion and facial pain. - Uncomplicated Urinary Tract Infection: eliminates uropathogens, leading to rapid symptom resolution. - Skin and Soft‑Tissue Infections: controls Gram‑positive and Gram‑negative bacteria, promoting wound healing. - Chronic Bacterial Prostatitis: reduces bacterial load in the prostate, alleviating urinary symptoms.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to arrhythmia - Clostridioides difficile‑associated colitis - Severe allergic reactions such as anaphylaxis - Peripheral neuropathy - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Levofloxacin requires careful patient assessment and monitoring.

- Assess renal function: dose adjustment may be required in impaired clearance. - Avoid use in patients with a history of tendon disorders: risk of tendon rupture is increased. - Use cautiously in individuals with known QT prolongation or electrolyte abnormalities. - Monitor for hypersensitivity reactions: discontinue if rash or anaphylaxis develops. - Store at room temperature: keep in the original container, protect from moisture and light.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids or supplements containing aluminum, magnesium or calcium: markedly reduce levofloxacin absorption. - NSAIDs (e.g., ibuprofen, naproxen): increase risk of central nervous system stimulation and seizures. - Corticosteroids: combined use heightens risk of tendon rupture.

Moderate Interactions (Monitor Closely): - Warfarin: levofloxacin may enhance anticoagulant effect, requiring INR monitoring. - Theophylline: possible increase in plasma concentrations, watch for toxicity. - QT‑prolonging drugs (e.g., macrolides, other fluoroquinolones): may compound cardiac risk.